276 related articles for article (PubMed ID: 31133384)
1. Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure.
Steiner N; Shrem G; Tannus S; Dahan SY; Balayla J; Volodarsky-Perel A; Tan SL; Dahan MH
Fertil Steril; 2019 Jul; 112(1):98-104. PubMed ID: 31133384
[TBL] [Abstract][Full Text] [Related]
2. Management of recurrent implantation failure by gonadotropin-releasing hormone agonist and aromatase inhibitor suppression, in women without evidence of endometriosis.
Khayat S; Elliott B; Dahan MH
Gynecol Endocrinol; 2019 Mar; 35(3):267-270. PubMed ID: 30328740
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF.
Cantor A; Tannus S; Son WY; Tan SL; Dahan MH
Reprod Biomed Online; 2019 Apr; 38(4):520-527. PubMed ID: 30935663
[TBL] [Abstract][Full Text] [Related]
4. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
5. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist downregulation combined with hormone replacement therapy improves the reproductive outcome in frozen-thawed embryo transfer cycles for patients of advanced reproductive age with idiopathic recurrent implantation failure.
Pan D; Yang J; Zhang N; Wang L; Li N; Shi J; Zhou H
Reprod Biol Endocrinol; 2022 Feb; 20(1):26. PubMed ID: 35115007
[TBL] [Abstract][Full Text] [Related]
7. Artificial Cycle with or without a Depot Gonadotropin-releasing Hormone Agonist for Frozen-thawed Embryo Transfer: An Assessment of Infertility Type that Is Most Suitable.
Xie D; Chen F; Xie SZ; Chen ZL; Tuo P; Zhou R; Zhang J
Curr Med Sci; 2018 Aug; 38(4):626-631. PubMed ID: 30128871
[TBL] [Abstract][Full Text] [Related]
8. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
9. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
10. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles.
Tatsumi T; Jwa SC; Kuwahara A; Irahara M; Kubota T; Saito H
Hum Reprod; 2017 Jun; 32(6):1244-1248. PubMed ID: 28398491
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.
Meyer L; Murphy LA; Gumer A; Reichman DE; Rosenwaks Z; Cholst IN
Fertil Steril; 2015 Sep; 104(3):637-42. PubMed ID: 26149355
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment with a gonadotropin-releasing hormone agonist and an aromatase inhibitor may improve outcomes in in vitro fertilization cycles of women with stage I-II endometriosis.
Piedimonte S; Volodarsky-Perel A; Tannus S; Tan SL; Dahan MH
F S Sci; 2020 Aug; 1(1):98-103. PubMed ID: 35559744
[TBL] [Abstract][Full Text] [Related]
14. The effects of letrozole on women with endometriosis undergoing ovarian stimulation for
Kim SJ; Choo CW; Kim SK; Lee JR; Jee BC; Suh CS; Lee WD; Kim SH
Gynecol Endocrinol; 2020 Mar; 36(3):257-260. PubMed ID: 31389274
[TBL] [Abstract][Full Text] [Related]
15. GnRH antagonist and letrozole co-treatment in diminished ovarian reserve patients: a proof-of-concept study.
Olgan S; Humaidan P
Reprod Biol; 2017 Mar; 17(1):105-110. PubMed ID: 28173995
[TBL] [Abstract][Full Text] [Related]
16. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
Ren J; Sha A; Han D; Li P; Geng J; Ma C
Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
[TBL] [Abstract][Full Text] [Related]
17. Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Vilos AG; Oraif A; Machado M; Abu-Rafea B; Vilos GA
J Obstet Gynaecol Can; 2019 Jun; 41(6):772-781. PubMed ID: 30413336
[TBL] [Abstract][Full Text] [Related]
18. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
[TBL] [Abstract][Full Text] [Related]
19. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
20. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]